(PC) Thompson v. Razavi

CourtDistrict Court, N.D. California
DecidedFebruary 27, 2023
Docket5:20-cv-04292
StatusUnknown

This text of (PC) Thompson v. Razavi ((PC) Thompson v. Razavi) is published on Counsel Stack Legal Research, covering District Court, N.D. California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
(PC) Thompson v. Razavi, (N.D. Cal. 2023).

Opinion

1 2 3 4 5 6 7 8 UNITED STATES DISTRICT COURT 9 NORTHERN DISTRICT OF CALIFORNIA 10 JOHN WILLIAM THOMPSON, 11 Case No. 5:20-cv-04292 EJD (PR) Plaintiff, 12 ORDER GRANTING DEFENDANT v. TARRARA’S MOTION FOR 13 SUMMARY JUDGMENT ERIC RAZAVI, et al., 14

Defendants. 15 (Docket No. 44) 16

17 Plaintiff, a California state prisoner proceeding pro se, filed this civil rights action 18 pursuant to 42 U.S.C. § 1983 against medical personnel at Correctional Training Facility 19 (“CTF”) in Soledad and at the California Health Care Facility (“CHCF”) in Stockton, 20 where he is currently incarcerated.1 Dkt. No. 1.2 The amended complaint, Dkt. No. 12, is 21 the operative complaint in this matter. See Dkt. No. 13.3 The Court found that Plaintiff’s 22 1 On June 29, 2020, the Eastern District of California transferred the matter here because a 23 substantial part of the allegations took place in Monterey County, which lies in the Northern District. Dkt. Nos. 5, 6. The matter was originally assigned to Magistrate Judge Jacqueline Scott 24 Corley, who ordered the matter reassigned to a district judge. Dkt. No. 7. The matter was reassigned to this Court on July 13, 2020. Dkt. No. 8. 25 2 All page references herein are to the Docket pages shown in the header to each document and brief cited on ECF, unless otherwise indicated. 26 3 The Court dismissed a claim against Defendant Dr. Singh at the California Health Care Facility 27 in Stockton as being improperly joined to this action under Federal Rule of Civil Procedure 20(a)(2). Dkt. No. 10 at 3. Plaintiff was directed to pursue the claim in a separate action in the 1 amended complaint, Dkt. No. 12, stated cognizable Eighth Amendment claims against 2 three Defendants. Dkt. No. 13 at 2. The Court granted summary judgment in favor of two 3 of the Defendants, Dr. Eric Razavi, DDS and Dr. Mary Sweet, MD. Dkt. No. 41. 4 The remaining Defendant, Dr. Tarrara, MD, has filed a motion for summary 5 judgment on grounds that Plaintiff failed to exhaust available administrative remedies as to 6 Plaintiff’s claims against Defendant Tarrara.4 Dkt. No. 44. Plaintiff responded, Dkt. No. 7 49, and Defendant Tarrara has replied, Dkt. No. 50. 8 For the reasons set forth below, Defendant Tarrara’s motion is GRANTED. 9 10 DISCUSSION 11 I. Statement of Facts5 12 Defendant Tarrara was Plaintiff’s primary care physician at CTF during the relevant 13 time frame in 2016. Dkt. No. 12 at 4; Dkt. No. 44-2 at 18. In about May 2016, Defendant 14 Tarrara discontinued one of Plaintiff’s pain medications, known as Gabapentin.6 15 Defendant Tarrara recommended continuing Morphine and Ibuprofen for pain. Dkt. No. 16 44-2 at 18. 17 On August 1, 2016, Plaintiff submitted a grievance asking to have the Gabapentin 18 medication reinstated “and/or be seen by a specialist for surgery.” Dkt. No. 44-2 at 7, 14, 19 16. Plaintiff stated he had been prescribed Gabapentin since 2008 and he was 20 experiencing severe pain since the Gabapentin was discontinued. Id. at 16. Plaintiff 21 claimed Defendant Tarrara lied to Plaintiff about the availability of Gabapentin, and that 22

23 4 Because of delays in identifying and serving Defendant Tarrara, Dkt. No. 12, Dkt. No. 40, his motion for summary judgment was filed more than six months after the motion 24 filed by Defendants Razavi and Sweet. Dkt. No. 36, Dkt. No. 41. 5 The following facts are not disputed unless otherwise stated. 25 6 Plaintiff refers to this medication as “Neurontin,” Dkt. No. 44-2 at 14, 16, whereas 26 Defendant Tarrara uses the name “Gabapentin,” Dkt. No. 44-2 at 18. Because Neurontin is merely a trade name for the chemical compound Gabapentin, the Court will use the term 27 “Gabapentin.” See https://en.wikipedia.org/wiki/Gabapentin ; https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=browseByLetter.page&p 1 Plaintiff had informed Defendant Tarrara that he had been on a number of other 2 medications, but they were ineffective and “just make my head & balance off.” Id. 3 Plaintiff complained that Defendant Tarrara refused to review the MRI that Plaintiff had 4 won in response to an earlier grievance. Id. Dr. Tarrara repeatedly “tried to take more 5 meds or change my medical status so he don[’]t have to review my medical appliance 6 chrono.” Id. 7 In Plaintiff’s amended complaint, he has also alleged that Defendant Tarrara 8 accused him of “malingering for narcotics” and “faking it.”7 Dkt. No. 12 at 4. According 9 to Plaintiff, such assumptions about Plaintiff’s motives caused delays in his ultimate 10 surgical treatment. Id. 11 On September 12, 2016, Plaintiff was interviewed about his grievance by R. 12 Branch, M.D., who is a Physician and Surgeon and Primary Care Physician. Dkt. No. 44-2 13 at 18. On September 14, 2016, Dr. Branch issued a first level response denying the portion 14 of Plaintiff’s grievance complaining about Defendant Tarrara’s order to stop Gabapentin. 15 Id. at 18-19. According to Dr. Branch’s reasoning, Defendant Tarrara discontinued 16 Gabapentin based on Plaintiff’s exam and history as of May 2016. Id. at 18. In the 17 interim, Plaintiff had undergone a surgical procedure (Laminectomy) in August 2016 to 18 treat a spinal abscess.8 Id. Dr. Branch advised Plaintiff to discuss his medication regimen 19 with his current Primary Care Physician (no longer Defendant Tarrara) because Plaintiff’s 20 medical condition had changed. Id. 21 In the same August 1, 2016 grievance, Plaintiff also asked to be seen by a surgical 22 specialist for pain in his back and leg and several issues with his spinal cord. Id. at 7, 14. 23 7 In his amended complaint, Plaintiff made these allegations jointly against both Defendant 24 Tarrara and Defendant Sweet. Dkt. No. 12 at 4 (Defendant Sweet was substituted for former Doe Defendant, id. at 2). However, Plaintiff’s grievance names only Defendant 25 Tarrara as the person who decided to discontinue Gabapentin. Dkt. No. 44-2 at 16. In its order granting summary judgment to Defendant Sweet, the Court found that Defendant 26 Sweet was an emergency room doctor, not a primary care physician, and thus had a different role than Defendant Tarrara. Dkt. No. 41 at 3. 27 8 Plaintiff was “admitted to NMC 8/11/16 - 8/26/16” for the surgical procedure. Dkt. No. 1 Dr. Branch indicated that Plaintiff’s second grievance issue, to see a surgical specialist, 2 had been granted in the form of the surgical treatment Plaintiff had received in August 3 2016. Id. at 18. Thus, Plaintiff’s grievance was deemed partially granted – i.e., as to 4 Plaintiff’s request for surgical evaluation. Id. at 18, 19. Dr. Branch’s response informed 5 Plaintiff of his right to appeal Dr. Branch’s first level response to the Health Care Appeals 6 Coordinator within 30 days. Id. at 19. Plaintiff did not appeal the first level response to 7 his grievance. 9 Dkt. No. 44-1 at 3 ¶¶ 8, 9; Dkt. No. 44-2 at 7 (Tracking Number CTF HC 8 16044353). 9 In his response to Defendant Tarrara’s motion, Plaintiff points to a grievance that he 10 initiated in November 2019. Dkt. No. 49 at 2; Dkt. No. 49-1 at 2-4. Plaintiff exhausted 11 the 2019 grievance. Dkt. No. 49-1 at 6-7. Defendant Tarrara replies that Plaintiff’s 2019 12 grievance was untimely, and “concerned a wholly different time period, other medical 13 staff, and different conditions than the circumstances surrounding Defendant Tarrar[a]’s 14 alleged actions identified in the operative complaint.” Dkt. No. 50 at 3 (referencing Dkt. 15 No. 49-1 at 2-4). The events Plaintiff complained of in his 2019 grievance also occurred at 16 a different facility. Id. Plaintiff’s 2019 grievance complained about “systemic behavior” 17 and specific issues with his then-current Primary Care Provider. Dkt. No. 49-1 at 2.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Booth v. Churner
532 U.S. 731 (Supreme Court, 2001)
Woodford v. Ngo
548 U.S. 81 (Supreme Court, 2006)
Dixon v. United States
548 U.S. 1 (Supreme Court, 2006)
Jones v. Bock
549 U.S. 199 (Supreme Court, 2007)
Juan Albino v. Lee Baca
747 F.3d 1162 (Ninth Circuit, 2014)
Carmen v. San Francisco Unified School District
237 F.3d 1026 (Ninth Circuit, 2001)
McKinney v. Carey
311 F.3d 1198 (Ninth Circuit, 2002)

Cite This Page — Counsel Stack

Bluebook (online)
(PC) Thompson v. Razavi, Counsel Stack Legal Research, https://law.counselstack.com/opinion/pc-thompson-v-razavi-cand-2023.